17-80219805-AAGACAGCTGAGACACAGGCTCTGGGGTCGGAAATGAGAGCCAGGAGGGCACCCTGTCTGCAGTCTCTGGGGACCGGAGCACCAGCCCCTCCTCTGGGATCCCCTCCCAAGAGGGATTTGAGATCCGTGGACCCCTGAGCCCTGGCTGGGCAGGGTCAGAGGAGGGTGGGACAGGCGGCACGAGGTAAGTGTAGGGGTGCTGGATGCTGGGGCTCACTCCTCCAGCCTTTGCTGCCCTCTCTGGGGAGACACCCGTGAAGAGTCTGGGGGCGGCACAGAGAGGAGGACGAGAGGGAATGGCAGCGGGGGATACAAGGGCAGGGCACACTAGGGTCAGCATTGACCACGGGTGGGGAGGAGGCCAGTGGCCACTTCCCCGGGCCACCGCAGGTGGGCGTGGGGGGGCGGCGCCGGCACTCACCGAGGAGCAGCAGTGCGTTCCGGGGACGCGCCCGGCAGAGCCCCAGGACTAGC-A
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate
The NM_000199.5(SGSH):c.36_88+420del variant causes a splice donor, splice donor 5th base, coding sequence, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Genomes: not found (cov: 32)
Consequence
SGSH
NM_000199.5 splice_donor, splice_donor_5th_base, coding_sequence, intron
NM_000199.5 splice_donor, splice_donor_5th_base, coding_sequence, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.520
Genes affected
SGSH (HGNC:10818): (N-sulfoglucosamine sulfohydrolase) This gene encodes the enzyme sulfamidase; one of several enzymes involved in the lysosomal degradation of heparan sulfate. Mutations in this gene are associated with the lysosomal storage disease mucopolysaccaridosis IIIA, also known as Sanfilippo syndrome A, which results from impaired degradation of heparan sulfate. Transcripts of varying sizes have been reported but their biological validity has not been determined. [provided by RefSeq, Jun 2017]
SLC26A11 (HGNC:14471): (solute carrier family 26 member 11) This gene encodes a member of the solute linked carrier 26 family of anion exchangers. Members of this family of proteins are essential for numerous cellular functions including homeostasis and intracellular electrolyte balance. The encoded protein is a sodium independent sulfate transporter that is sensitive to the anion exchanger inhibitor 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.07090788 fraction of the gene.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-80219805-AAGACAGCTGAGACACAGGCTCTGGGGTCGGAAATGAGAGCCAGGAGGGCACCCTGTCTGCAGTCTCTGGGGACCGGAGCACCAGCCCCTCCTCTGGGATCCCCTCCCAAGAGGGATTTGAGATCCGTGGACCCCTGAGCCCTGGCTGGGCAGGGTCAGAGGAGGGTGGGACAGGCGGCACGAGGTAAGTGTAGGGGTGCTGGATGCTGGGGCTCACTCCTCCAGCCTTTGCTGCCCTCTCTGGGGAGACACCCGTGAAGAGTCTGGGGGCGGCACAGAGAGGAGGACGAGAGGGAATGGCAGCGGGGGATACAAGGGCAGGGCACACTAGGGTCAGCATTGACCACGGGTGGGGAGGAGGCCAGTGGCCACTTCCCCGGGCCACCGCAGGTGGGCGTGGGGGGGCGGCGCCGGCACTCACCGAGGAGCAGCAGTGCGTTCCGGGGACGCGCCCGGCAGAGCCCCAGGACTAGC-A is Pathogenic according to our data. Variant chr17-80219805-AAGACAGCTGAGACACAGGCTCTGGGGTCGGAAATGAGAGCCAGGAGGGCACCCTGTCTGCAGTCTCTGGGGACCGGAGCACCAGCCCCTCCTCTGGGATCCCCTCCCAAGAGGGATTTGAGATCCGTGGACCCCTGAGCCCTGGCTGGGCAGGGTCAGAGGAGGGTGGGACAGGCGGCACGAGGTAAGTGTAGGGGTGCTGGATGCTGGGGCTCACTCCTCCAGCCTTTGCTGCCCTCTCTGGGGAGACACCCGTGAAGAGTCTGGGGGCGGCACAGAGAGGAGGACGAGAGGGAATGGCAGCGGGGGATACAAGGGCAGGGCACACTAGGGTCAGCATTGACCACGGGTGGGGAGGAGGCCAGTGGCCACTTCCCCGGGCCACCGCAGGTGGGCGTGGGGGGGCGGCGCCGGCACTCACCGAGGAGCAGCAGTGCGTTCCGGGGACGCGCCCGGCAGAGCCCCAGGACTAGC-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 2028484.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SGSH | NM_000199.5 | c.36_88+420del | splice_donor_variant, splice_donor_5th_base_variant, coding_sequence_variant, intron_variant | 1/8 | ENST00000326317.11 | NP_000190.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SGSH | ENST00000326317.11 | c.36_88+420del | splice_donor_variant, splice_donor_5th_base_variant, coding_sequence_variant, intron_variant | 1/8 | 1 | NM_000199.5 | ENSP00000314606 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Mucopolysaccharidosis, MPS-III-A Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 01, 2022 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant has not been reported in the literature in individuals affected with SGSH-related conditions. This variant is not present in population databases (gnomAD no frequency). This variant results in the deletion of part of exon 1 (c.36_88+420del) of the SGSH gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in SGSH are known to be pathogenic (PMID: 11182930, 21204211, 22976768). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.